Lýsi sem hægðalyf - Lýsi sem hægðalyf

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2010-018761-35-IS

Enrollment

Registered

2010-03-08

Start date

2010-04-19

Completion date

Unknown

Last updated

2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The primary objective of this trial is to investigate the laxative effect of Lýsi as compared to Klyx. Otherwise healthy volunteers undergoing recto/recto-sigmoidscopy by an specialist in gastroenterology on a outpatient basis for various conditions as haemorrhoids, minor bleedings, polyp control, control after surgery

Interventions

Product Name: Lýsisstílar Product Code: 30FFA4 Pharmaceutical Form: Suppository INN or Proposed INN: Fish oil Concentration unit: % perc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Otherwise healthy volunteers over age 18 undergoing recto rectosigmoidscopy by a specialist in gastroenterology on an outpatient basis for various conditions as haemorrhoids, minor bleedings, polyp control, control after surgery Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Age under 18, nursing women, ongoing rectal bleeding, diarrhoea, known rectosigmoidis.

Design outcomes

Primary

Measure	Time frame
Main Objective: To investigate the laxative effects of lýsisstílar as compared to Klyx; Secondary Objective: Safety ; Primary end point(s): Rectal cleansing as compared to Klyx.	—

Countries

Iceland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026